LHLiang Huang

Liang Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liang Huang has a total of 130 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ultrabright Quasi-Compact Quantum Dot Assembly for Sensitive and Color-Fixed Immunoassays

    by Sai Chu, Lijiao Ao, Jing Wang, Meng Xu, Bianlong Wang, Dinglv Zhuo, Yefeng Zhu, Jun Hu, Liang Huang

    Home-based immunoassay platforms constitute critical tools for the rapid screening of infectious respiratory viruses. Notably, viral loads can remain low at certain stages yet vary over several orders of magnitude during infection, and such variations are closely associated with the disease progression and transmission potential. This self-testing demand necessitates diagnostic kits that combine high sensitivity with accurate human-vision discriminability and portable terminal quantification across the entire detectable range. In response, an ultrabright label was fabricated via template-confined, quasi-compact stacking of quantum dots (QDs). This architecture retained high photoluminescence quantum yield with an elevated QD accumulation number, substantially amplifying the immunosignal output and thereby lowering the limit of detection (LOD). Inspired by the highly discernible visualization principle of multi-index universal pH strips, a color-fixed lateral flow immunoassay (c-LFIA) was established by antigen-driven production of composite colors through narrow-emissive dual QD constituent emitters. This strategy enabled sensitive and discriminable chromatic gradients that were assigned unique identification codes to successive antigen-concentration intervals. Accordingly, the c-LFIA could visually categorize SARS-CoV-2 antigen concentration into 9 discrete intervals spanning 0.1–2000 ng mL−1 with an average interpretation accuracy of 90.19%, while portable terminal analysis achieved a quantitative LOD of 47 pg mL−1. Clinical validation further demonstrated an accurate 6-tier viral abundance-associated category stratification by user visual inspection, complemented by companion one-click smartphone reporting of diagnostic information, thus facilitating decentralized detection and scientific response to respiratory pathogen infections.

  • Turn-On Near-Infrared Lateral Flow Immunoassay with Synergistic Energy Transfer for Direct and Ultrasensitive Detection in Complex Matrices

    by Jingrui Yuan, Liang Huang, Yaqi Luo, Jing Wang

    The rapid, sensitive, and quantitative detection of small-molecule analytes in complex matrices remains fundamentally constrained by severe optical interference and limited signal transduction efficiency. Herein, we report a turn-on near-infrared (NIR) fluorescence lateral flow immunoassay (NFLFIA) that integrates indocyanine green-embedded nanoparticles and horseradish peroxidase-loaded gold nanorods as a spectrally matched donor–acceptor pair. Benefiting from the intrinsically low optical background of the NIR window and a cascade quenching mechanism governed by synergistic inner-filter effect and Förster resonance energy transfer, the NFLFIA enables ultrasensitive detection of aflatoxin M1 over an exceptionally broad dynamic range spanning 4 orders of magnitude, with a low limit of detection of 10.3 fg mL–1. With a sample-to-answer time of 30 min, this portable NIR-readout platform achieves sensitivity 3 orders of magnitude higher than commercial colloidal gold strips and delivers more reliable quantitative performance than 3-h-long enzyme-linked immunosorbent assays. This work establishes a robust and field-deployable platform for rapid, on-site monitoring of trace-level small molecules in complex matrices.

  • Top Cited Papers

    A Dual-Hue Recognizable Lateral Flow Immunoassay Corresponding to Distinct Sensitivity Ranges for Timely and Quantitative Diagnosis of Prostate Cancer

    by Rong Hu, Xueqiang Zhang, Liang Huang, Jun Hu, Jing Wang

    Early cancer screening is pivotal for reducing mortality yet remains constrained by the trade-off between analytical accuracy and operational simplicity. Here, we present a dual-hue recognizable lateral flow immunoassay (DHLFIA) that enables rapid, quantitative, and user-friendly detection of prostate cancer biomarkers. The platform integrates dual-ratiometric fluorescence transitions, establishing two hue recognition pathways (green-to-red and blue-to-red) with distinct sensitivities for the precise quantification of total (t-PSA) and free (f-PSA) prostate-specific antigens. The differentiated color responsiveness of the two ratio system, governed by the inner filter effect, was elucidated both theoretically and experimentally. This dual-hue strategy enables semiquantitative visual discrimination of the clinically significant “gray zone” (t-PSA: 4–10 ng/mL) by the naked eyes, while smartphone-based tonal analysis of the f-PSA/t-PSA ratio (cutoff = 0.16) allows accurate risk stratification within this range. Validated with clinical serum samples, the DHLFIA achieved a diagnostic accuracy of 96.7%, comparable to chemiluminescent assays, yet offered markedly improved speed and ease of operation. By coupling a modular design with dual-ratiometric readout principles, this work establishes a generalizable framework for multiplexed, point-of-care diagnostics of noncommunicable diseases.


  • Spatially Layered Dual-Porous Nanohybrids Enabling a Colorimetric-Fluorometric-Catalytic Continuous Gradient Signal Response for High-Performance Immunochromatographic Diagnosis

    by Liang Huang, Hui Chang, Huanhuan Han, Lijiao Ao, Jing Wang

    Achieving high sensitivity, a broad linear range, and accurate quantification in lateral flow immunoassays (LFIAs) remains a significant challenge, particularly due to limitations in signal mode integration. Herein, we report a novel multifunctional "three-in-one" nanohybrid (SQF@ZIF-8/Pt) that addresses these issues by spatially integrating colorimetric, fluorometric, and catalytic functionalities within a single probe. Unlike conventional LFIA probes, this nanohybrid features a well-defined hierarchical architecture constructed through dendritic and mesoporous dual scaffolds, enabling continuous and overlapping signal output across a wide concentration range. Applied to SARS-CoV-2 nucleocapsid protein detection, the developed LFIA enables colorimetric quantification over 4 orders of magnitude (0.025-100 ng/mL) with a detection limit of 0.0302 ng/mL. Furthermore, fluorescence-based secondary quantification within the overlapping concentration range (0.5-10 ng/mL) allows internal signal cross-validation, improving result accuracy. Clinical validation demonstrated that this assay not only outperforms conventional colloidal gold-based LFIAs in sensitivity but also exhibits superior resistance to matrix interference, demonstrating strong potential for reliable point-of-care diagnostics.


  • Semiconductor Nanoplatelets Based Host‐Guest Assembly Structure with High Color Purity for Hue‐Recognizable Lateral Flow Immunoassay

    by Yefeng Zhu, Lijiao Ao, Sai Chu, Yuting Liao, Jing Wang, Jun Hu, Liang Huang

    The hue‐recognition based point‐of‐care diagnosis favorites both human visual perception and imaging analysis with portable terminals. Semiconductor nanoplatelets (NPLs) as an emerging narrow‐emissive fluorophore particularly suit above color‐purity desired diagnosis, but are hindered by their intrinsic hydrophobicity and difficulty in controlled assembly. Here the host‐guest assembling of hydrophobic NPLs are developed within 3D porous space of dendritic templates, and stepwise surface silanization to fabricate silica‐NPLs‐silica structure (SNS). The structure enables high fluorescence of single assembly reaching 246‐fold and 4‐fold brightness of single NPL and commercial europium‐doped polystyrene bead. The strategy is compatible with various colored NPLs (≈540–640 nm emission) and provides stable aqueous colloids with well‐preserved emission. The high brightness and narrow emission of SNS enable both signal amplification and visual/image color discrimination. The hue‐recognizable lateral flow immunoassay for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) nucleocapsid protein reveals an average naked‐eye interpretation accuracy of 92.9% over six concentration levels referring to standard card, accompanied by a quantification linear range of 0.13–200 ng mL−1 and a limit of detection of 0.13 ng mL−1 by smartphone. The diagnostic results for SARS‐CoV‐2 positive clinical samples demonstrate easily distinguishable antigen positive levels based on hue‐gradients, which holds significance for home‐based self‐testing of pathogens.


  • CRISPR–Cas12a-Mediated Hue-Recognition Lateral Flow Assay for Point-of-Need Detection of Salmonella

    by Jingrui Yuan, Liu Wang, Liang Huang, Kaiyu He, Hongmei Wang, Xiahong Xu, Bin Su, Jing Wang

    Nucleic acid detection of pathogens in a point-of-need (PON) manner is of great significance yet remains challenging for sensitive and accurate visual discrimination. Here, we report a CRISPR-Cas12a-mediated lateral flow assay for PON detection of Salmonella typhimurium (S.ty) that is a prevailing pathogen disseminated through tainted food. The variation of the fluorescence color of the test line is exploited to interpret the results, enabling the discrimination between positive and negative samples on the basis of a hue-recognition mechanism. By leveraging the cleavage activity of Cas12a and hue-recognition readout, the assay facilitated by recombinase polymerase amplification can yield a visual detection limit of 1 copy μL-1 for S.ty genomic DNA within 1 h. The assay also displays a high specificity toward S.ty in fresh chicken samples, as well as a sensitivity 10-fold better than that of the commercial test strip. Moreover, a semiquantitative detection of S.ty ranging from 0 to 4 × 103 CFU/mL by the naked eye is made possible, thanks to the easily discernible color change of the test line. This approach provides an easy, rapid, accurate, and user-friendly solution for the PON detection of Salmonella and other pathogens.


  • Gold–Silver Alloy Nanoparticle-Incorporated Pitaya-Type Silica Nanohybrids for Sensitive Competitive Lateral Flow Immunoassay

    by Lu Tong, Daquan Li, Mei Huang, Liang Huang, Jing Wang

    Although the competitive lateral flow immunoassay (CLFIA) using gold nanoparticles (AuNPs) as labels has been widely adopted for the rapid detection of small molecules, its sensitivity is often constrained by the insufficient colorimetric signal produced by conventional AuNPs labels. Herein, we introduce a new type of intensified colorimetric label, denoted as SAAS, which is engineered by integrating gold-silver alloy nanoparticles (Au-Ag NPs) within a dendritic silica scaffold. These pitaya-type silica nanohybrids combine the advantages of the amplified molar extinction coefficient of alloy units with the signal collective effect of numerous Au-Ag NPs in a singular label. The SAAS-based CLFIA strips not only achieve qualitative screening of aflatoxin B1 (AFB1) at an extraordinarily low concentration of 0.2 ng/mL by the naked eye but also enable precise AFB1 quantification through a smartphone, with a remarkable limit of detection of 0.00314 ng/mL. Moreover, by leveraging SAAS as a quencher, we have delved into transforming the conventional signal-off mode of competitive immunoassay into a signal-on configuration. This innovation led to the development of a fluorescent LFIA that augments interpretative precision and sensitivity. Our study demonstrates the substantial potential of the proposed nanohybrid labels in enhancing the sensitivity of CLFIA for detecting small molecules.


  • Hue Recognition Competitive Fluorescent Lateral Flow Immunoassay for Aflatoxin M1 Detection with Improved Visual and Quantitative Performance

    by Jing Wang, Chenxing Jiang, Jingrui Yuan, Lu Tong, Yang Wang, Dinglv Zhuo, Liang Huang, Weihong Ni, Jiafeng Zhang, Mei Huang, et al.

    Immunological detection of small molecules in a point-of-care (POC) format is of great significance yet remains challenging for accurate visual discrimination and quantitative analysis. Here, we report a novel hue recognition competitive fluorescent lateral flow immunoassay (HCLFIA) strip that allows both visual and quantitative detection of aflatoxin M1 (AFM1). The HCLFIA strip works on the basis of the ratiometric change of emission, arising from the overlap of fluorescence signals of two nanocomposites tagged with probe antibodies and coated antigens. A visually discernible orange-red-to-green fluorescence color change allows the naked eye semiquantitative readout of AFM1 around the threshold concentration (0.05 ng mL-1), yielding a visible detection limit of 0.02 ng mL-1. Moreover, using a custom smartphone-based device and color chart analysis, ultrasensitive quantitative detection of AFM1 can be achieved with a low limit of detection at 0.0012 ng mL-1, which is considerably better than those of the previously reported colorimetric and fluorescent strips. The accuracy performed in spiked milk samples ranged from 97.91 to 113.12% with a coefficient of variation below 7.8%, showing good consistency with the results from isotope dilution liquid chromatography-tandem mass spectrometry. Thanks to the unique hue recognition scheme, the HCLFIA strip holds great potential for POC detection of small molecules.